MATD3 Stock Overview
Provides health services in Brazil. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Hospital Mater Dei S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$4.30 |
| 52 Week High | R$8.69 |
| 52 Week Low | R$4.06 |
| Beta | 0.49 |
| 11 Month Change | -2.27% |
| 3 Month Change | -7.33% |
| 1 Year Change | -43.50% |
| 33 Year Change | -73.11% |
| 5 Year Change | n/a |
| Change since IPO | -74.40% |
Recent News & Updates
Recent updates
Shareholder Returns
| MATD3 | BR Healthcare | BR Market | |
|---|---|---|---|
| 7D | -5.3% | 0.3% | -0.06% |
| 1Y | -43.5% | -13.6% | -1.6% |
Return vs Industry: MATD3 underperformed the BR Healthcare industry which returned -13.6% over the past year.
Return vs Market: MATD3 underperformed the BR Market which returned -1.6% over the past year.
Price Volatility
| MATD3 volatility | |
|---|---|
| MATD3 Average Weekly Movement | 5.2% |
| Healthcare Industry Average Movement | 6.1% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in BR Market | 8.5% |
| 10% least volatile stocks in BR Market | 2.3% |
Stable Share Price: MATD3 has not had significant price volatility in the past 3 months compared to the BR market.
Volatility Over Time: MATD3's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1973 | n/a | Jose Henrique Salvador | www.materdei.com.br |
Hospital Mater Dei S.A. provides health services in Brazil. The company offers hospital, surgeries, oncology, medical appointments, exams, and other services. Hospital Mater Dei S.A. was founded in 1973 and is headquartered in Belo Horizonte, Brazil.
Hospital Mater Dei S.A. Fundamentals Summary
| MATD3 fundamental statistics | |
|---|---|
| Market cap | R$1.52b |
| Earnings (TTM) | -R$320.92m |
| Revenue (TTM) | R$2.28b |
0.7x
P/S Ratio-4.7x
P/E RatioIs MATD3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MATD3 income statement (TTM) | |
|---|---|
| Revenue | R$2.28b |
| Cost of Revenue | R$1.58b |
| Gross Profit | R$704.31m |
| Other Expenses | R$1.03b |
| Earnings | -R$320.92m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.91 |
| Gross Margin | 30.89% |
| Net Profit Margin | -14.07% |
| Debt/Equity Ratio | 97.6% |
How did MATD3 perform over the long term?
See historical performance and comparison